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(1) (1) Figure S4 . Mass spectrometry analysis confirming the production of pregn-1,4-diene-3,20-dione (PDD) from pregn-4-ene-3,20-dione (PD). (a) Representative RP-HPLC chromatogram generated from clarified bacterial lysates of E. coli expressing D 1 -KstD R following incubation with 50 µM PD and 50 µM C2,3,4-13 C-PD (t r = 16.45 min) for 24 hours. Figure S7 . 3-ketosteroid-9a-hydroxylase (Kst-9αH) hydroxylates C-9 of cholestenone (CN) to produce 9-hydroxycholeste-4-ene-3-one (9-OHCN). Clarified lysates produced in an identical manner from either E. coli expressing Kst-9αH or E. coli transformed with an empty (pUC19) expression plasmid (control) were incubated with CN for 24 hours. Following incubation, lipids were extracted and analyzed by RP-HPLC as described in the methods. 
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Cholestenone (µM) Figure S16 Expression, purification, and activity assessment of recombinant Δ 1 -KstD R . Recombinant Δ 1 -KstD R , expressed as FLAG-HP-THX-Δ 1 -KstD R fusion protein in E. coli was partially purified using immobilized metal affinity chromatography (IMAC) and analyzed for purity and activity. (a) Image of a representative in-gel nitrotetrazolium blue (NTB) activity assay ( Figure S17 . Nitrotetrazolium blue (NTB) reaction mechanism. The NTB assay is based of an indirectly coupled redox reaction that allows the assessment of the relative dehydrogenase activity within a sample. The reaction proceeds with the removal of two protons and two electrons from pregn-4-ene-3,20-dione (PD) by D 1 -KstD to form pregn-1,4-diene-3,20-dione (PDD). The protons and electrons are donated from the FADH of D 1 -KstD to the intermediate electron acceptor, phenazine methylsulfate (PMS). PMS relays the electrons to NTB where the center tetrazolium ring is reduced to formazan. The reaction causes NTB, which in the oxidized state forms a soluble yellow solution, to transition into an insoluble purple precipitate as dehydrogenation occurs. The assay was used in a native-PAGE format to assess the relative dehydrogenase activity from fractions produced during the purification of D 1 -KstD R by immobilized metal affinity chromatography (IMAC) as described in the methods. Figure S22 . Generation of 9-hydroxypregn-4-ene-3,20-dione (9-OHPD). Clarified lysates produced from E. coli expressing 3-ketosteroid-9a-hydroxylase (Kst-9αH) were incubated with pregn-4-ene-3,20-dione (PD) for 48 hours. Following incubation, lipids were extracted and analyzed by RP-HPLC as described in the methods. (a) Structures and reaction summary. (b) Representative HPLC chromatogram of the 9-OHPD (l max : 245 nm; t r = 5.2 min) product produced and isolated from clarified lysate. Figure S23 . Overview of the humanized cholesterol-3-OH dehydrogenase (CholD) expression construct. The CholD expression construct encodes the CholD nucleotide sequence fused with a 5' Tobacco Etch Virus (TEV) protease recognition site, 6xHis tag to aid purification, a Kozak consensus sequence for translation initiation, and a FLAG tag to aid in detection. Flanking attB attachment sites were added to aid subcloning via Gateway cloning. Details are provided in Methods and the nucleotide sequence is provided in Table S1 . Table  S2 . Figure S26 . Overview of the 3-ketosteroid 9a-hydroxylase (Kst-9aH) expression construct used for expression in E. coli. The nucleotide sequence encoding the A (Kst-9aHA) and B (Kst-9aHB) subunits of Kst-9aH were fused with 5' Shine Dalgarno sequences for translation initiation, short linker peptides (amino acids: GAS), and 6x His tags to aid purification. The Kst-9aH expression construct was designed as a bicistronic construct by inserting a second shine dalgarno sequence following the 3' end of Kst-9aHA. The second Shine Dalgarno sequence was shifted by one nucleotide to produce a second open reading frame for coexpression of Kst-9aHB. Flanking attB attachment sites were added to aid subcloning via Gateway cloning. Details are provided in Methods and the nucleotide sequence is provided in Table S4 . 
